Literature DB >> 19556858

Functional targeting of the MUC1 oncogene in human cancers.

Donald W Kufe1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19556858      PMCID: PMC3035104          DOI: 10.4161/cbt.8.13.8844

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


× No keyword cloud information.
  64 in total

1.  Cell-associated episialin is a complex containing two proteins derived from a common precursor.

Authors:  M J Ligtenberg; L Kruijshaar; F Buijs; M van Meijer; S V Litvinov; J Hilkens
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

2.  Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.

Authors:  D F Hayes; V R Zurawski; D W Kufe
Journal:  J Clin Oncol       Date:  1986-10       Impact factor: 44.544

3.  Suppression of cellular aggregation by high levels of episialin.

Authors:  M J Ligtenberg; F Buijs; H L Vos; J Hilkens
Journal:  Cancer Res       Date:  1992-04-15       Impact factor: 12.701

4.  Structural analysis of the DF3 human breast carcinoma-associated protein.

Authors:  M Abe; D Kufe
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

5.  Episialin (MUC1) inhibits cytotoxic lymphocyte-target cell interaction.

Authors:  E van de Wiel-van Kemenade; M J Ligtenberg; A J de Boer; F Buijs; H L Vos; C J Melief; J Hilkens; C G Figdor
Journal:  J Immunol       Date:  1993-07-15       Impact factor: 5.422

6.  Purification and characterization of a high molecular weight glycoprotein detectable in human milk and breast carcinomas.

Authors:  H Sekine; T Ohno; D W Kufe
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

7.  Tumor selective reactivity of a monoclonal antibody prepared against a recombinant peptide derived from the DF3 human breast carcinoma-associated antigen.

Authors:  L Perey; D F Hayes; P Maimonis; M Abe; C O'Hara; D W Kufe
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

8.  A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats.

Authors:  S Gendler; J Taylor-Papadimitriou; T Duhig; J Rothbard; J Burchell
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.157

9.  Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein.

Authors:  P Pandey; S Kharbanda; D Kufe
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

10.  Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen.

Authors:  J Siddiqui; M Abe; D Hayes; E Shani; E Yunis; D Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

View more
  53 in total

1.  MUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLC.

Authors:  Maroof Alam; Rehan Ahmad; Hasan Rajabi; Donald Kufe
Journal:  Mol Cancer Res       Date:  2014-11-03       Impact factor: 5.852

Review 2.  The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma.

Authors:  Alphonse E Sirica
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-11-29       Impact factor: 46.802

3.  A monoclonal antibody against the oncogenic mucin 1 cytoplasmic domain.

Authors:  Govind Panchamoorthy; Hala Rehan; Akriti Kharbanda; Rehan Ahmad; Donald Kufe
Journal:  Hybridoma (Larchmt)       Date:  2011-12

4.  The MUC1-C oncoprotein as a target in hematologic malignancies.

Authors:  Jeffrey Schlom
Journal:  Cancer Biol Ther       Date:  2010-09-26       Impact factor: 4.742

5.  Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways.

Authors:  Mengying Yao; Weihong Zhang; Qingxian Zhang; Lihua Xing; Aiguo Xu; Qiuhong Liu; Bing Cui
Journal:  Lung       Date:  2011-10-01       Impact factor: 2.584

6.  MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR.

Authors:  Hasan Rajabi; Caining Jin; Rehan Ahmad; Cain McClary; Maya Datt Joshi; Donald Kufe
Journal:  Genes Cancer       Date:  2010-01-01

7.  MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor.

Authors:  V Genitsch; I Zlobec; G N Thalmann; A Fleischmann
Journal:  Prostate Cancer Prostatic Dis       Date:  2016-05-10       Impact factor: 5.554

8.  Targeting MUC1-C is synergistic with bortezomib in downregulating TIGAR and inducing ROS-mediated myeloma cell death.

Authors:  Li Yin; Turner Kufe; David Avigan; Donald Kufe
Journal:  Blood       Date:  2014-03-14       Impact factor: 22.113

9.  MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells.

Authors:  Hasan Rajabi; Rehan Ahmad; Caining Jin; Maya Datt Joshi; Minakshi Guha; Maroof Alam; Surender Kharbanda; Donald Kufe
Journal:  Prostate       Date:  2012-04-02       Impact factor: 4.104

Review 10.  Glycosylation: a hallmark of cancer?

Authors:  Bhairavi N Vajaria; Prabhudas S Patel
Journal:  Glycoconj J       Date:  2016-12-14       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.